Elevated transaminases and hypoalbuminemia in Covid-19 are prognostic factors for disease severity.

dc.contributor.author

Wagner, Jason

dc.contributor.author

Garcia-Rodriguez, Victor

dc.contributor.author

Yu, Abraham

dc.contributor.author

Dutra, Barbara

dc.contributor.author

Larson, Scott

dc.contributor.author

Cash, Brooks

dc.contributor.author

DuPont, Andrew

dc.contributor.author

Farooq, Ahmad

dc.date.accessioned

2021-05-28T02:19:04Z

dc.date.available

2021-05-28T02:19:04Z

dc.date.issued

2021-05-13

dc.date.updated

2021-05-28T02:19:03Z

dc.description.abstract

Prognostic markers are needed to understand the disease course and severity in patients with Covid-19. There is evidence that Covid-19 causes gastrointestinal symptoms and abnormalities in liver enzymes. We aimed to determine if hepatobiliary laboratory data could predict disease severity in patients with Covid-19. In this retrospective, single institution, cohort study that analyzed patients admitted to a community academic hospital with the diagnosis of Covid-19, we found that elevations of Aspartate Aminotransferase (AST), Alanine Aminotransferase (ALT) and Alkaline Phosphatase (AP) at any time during hospital admission increased the odds of ICU admission by 5.12 (95% CI: 1.55-16.89; p = 0.007), 4.71 (95% CI: 1.51-14.69; p = 0.01) and 4.12 (95% CI: 1.21-14.06, p = 0.02), respectively. Hypoalbuminemia found at the time of admission to the hospital was associated with increased mortality (p = 0.02), hypotension (p = 0.03), and need for vasopressors (p = 0.02), intubation (p = 0.01) and hemodialysis (p = 0.002). Additionally, there was evidence of liver injury: AST was significantly elevated above baseline in patients admitted to the ICU (54.2 ± 15.70 U/L) relative to those who were not (9.2 ± 4.89 U/L; p = 0.01). Taken together, this study found that hypoalbuminemia and abnormalities in hepatobiliary laboratory data may be prognostic factors for disease severity in patients admitted to the hospital with Covid-19.

dc.identifier

10.1038/s41598-021-89340-y

dc.identifier.issn

2045-2322

dc.identifier.uri

https://hdl.handle.net/10161/23222

dc.language

eng

dc.publisher

Springer Science and Business Media LLC

dc.relation.ispartof

Sci Rep

dc.relation.isversionof

10.1038/s41598-021-89340-y

dc.title

Elevated transaminases and hypoalbuminemia in Covid-19 are prognostic factors for disease severity.

dc.type

Journal article

pubs.begin-page

10308

pubs.issue

1

pubs.organisational-group

School of Medicine

pubs.organisational-group

Medicine, Gastroenterology

pubs.organisational-group

Duke

pubs.organisational-group

Medicine

pubs.organisational-group

Clinical Science Departments

pubs.publication-status

Published online

pubs.volume

11

Files